Abstract:e14542 Background: Immunosuppressive factors in the tumor microenvironment reduce the therapeutic efficacy of cancer vaccines; therefore, dampening the tumor immunosuppressive environment while activating antitumor immunity should be a useful approach for cancer therapy. Cancer-associated fibroblasts (CAFs) are among the most important cellular components of the tumor microenvironment and play an important role in the development and progression of tumors. Fibroblast activation protein α (FAPα) is a type II transmembrane protein specifically expressed by CAFs in most epithelial cancers. Gene sequence homology between human and murine FAPα is 90%. Heterogeneity of genes in the evolution of the formation of such nuances can be utilized to break immune tolerance, enhance immunogenicity, induce tumour cell autoimmune responses and thus inhibit tumor growth. Methods: Tumor cells were transfected with human FAPα plasmids employing the cationic lipid DOTAP. Its antitumor effects were investigated in three established tumor models. The potential immune mechanisms were investigated through adoptive immunotherapy and 51Cr release assay. The distributions of the immune cells in the tumor microenvironment were detected by immunohistochemical staining and flow cytometry. Results: Our results shown that whole tumor cell vaccine expressing human FAPα significantly inhibit tumor growth and prolong the survival of tumor bearing mice. This antitumor immune response was involved both of cellular and humoral immune responses. FAPα specific neutralizing antibodies were found in the serum of vaccinated mice and CAFs were significantly reduced within the tumors. Furthermore, this vaccine enhanced the infiltration of CD4+ T cells and CD8+ T cells, and suppressed the accumulation of immunosuppressive cells in the tumor microenvironment. Conclusions: These findings suggest that whole tumor cell vaccine expressing human FAPα inhibit tumor growth by producing FAPα specific neutralizing antibodies and CTLs, and targeting tumor cells and CAFs. These observations provide a new strategy for the clinical use of genetically modified tumor cells as cancer vaccines.

Anti-tumor effects of tumor cell vaccine by epigenetic modification on pancreatic cancer of hamster

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

The Immunotherapeutic Effect of Dendritic Cells Vaccine Modified with Interleukin-18 Gene and Tumor Cell Lysate on Mice with Pancreatic Carcinoma

Establishment of animal model of pancreatic carcinoma in Syrian golden hamsters

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Xiao Chai Hu Tang alleviates the Pancreatic Tumorigenesis via improving the mtDNA N6-Methyladenine Modification mediated Mitochondrial Dysfunction in Syrian Hamster model

Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine

ANTITUMOR EFFECT OF ANGIOSTATIN ON LIVER METASTASIS OF PANCREATIC CANCER IN SYRIAN GOLDEN HAMSTER MODEL

Anti-tumor Effects of Dendritic Cell Vaccine Pulsed with Rat Pancreatic Cancer Cell Lysate on Rat Pancreatic Cancer

Regression of Human Pancreatic Tumor Xenografts in Mice after a Single Systemic Injection of Recombinant Vaccinia Virus GLV-1h68.

Antitumor Activity of Mhsp65-Ttl Enhanced by Administration of Low Dose Cyclophosphamide in Pancreatic Cancer-Bearing Mice

Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells

Prophylactic Dendritic Cell Vaccination Controls Pancreatic Cancer Growth in a Mouse Model.

Antitumor Efficacy Induced By A B16f10 Tumor Cell Vaccine Treated With Mitoxantrone Alone Or In Combination With Reserpine And Verapamil In Mice

Dendritic Cell Immunotherapy Induces Anti-Tumor Effect in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma.

Anti-tumor Effect of Tumor Vaccine Combined with Metronomic Chemotherapy on Breast Cancer in Mice

Effect of melatonin on the pancreatic cancer in mice subcutaneous xenograft

Biological Nanoparticles Carrying the Hmda-7 Gene Are Effective in Inhibiting Pancreatic Cancer in Vitro and in Vivo

CAFs/tumor Cells Co-Targeting DNA Vaccine in Combination with Low-Dose Gemcitabine for the Treatment of Panc02 Murine Pancreatic Cancer

Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease

Antitumor Effect of a Whole Tumor Cell Vaccine Expressing Human Fibroblast Activation Protein in Murine Tumor Models.